- BDBM84738 CAS_16105-77-4 Fenfluramine (-) Fenfluramine (+) Fenfluramine NSC_3337 d-Fenfluramine
- NSC_65801 BDBM85596 CAS_3239-45-0 d-Fenfluramine
- NSC_65801 l-Fenfluramine BDBM85597 CAS_37577-24-5
- Norfenfluramine (+) d-Norfenfluramine Nor-dexfenfluramine BDBM85530 Norfenfluramine (-) Nor-d-fenfluramine Norfenfluramine
- Fitzgerald, LW; Burn, TC; Brown, BS; Patterson, JP; Corjay, MH; Valentine, PA; Sun, JH; Link, JR; Abbaszade, I; Hollis, JM; Largent, BL; Hartig, PR; Hollis, GF; Meunier, PC; Robichaud, AJ; Robertson, DW Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57: 75-81 (2000)
- Rothman, RB; Baumann, MH; Savage, JE; Rauser, L; McBride, A; Hufeisen, SJ; Roth, BL Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102: 2836-41 (2000)
- Setola, V; Hufeisen, SJ; Grande-Allen, KJ; Vesely, I; Glennon, RA; Blough, B; Rothman, RB; Roth, BL 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 63: 1223-9 (2003)